Companion Animal Speciality Drugs Market: Veterinary Clinics Distribution Channel Segment to Dominate the Global Market Through 2027: Global Industry Analysis and Opportunity Assessment 2017-2027
- Healthcare, Pharmaceuticals and Medical devices
- No. of Pages: 199
- Published: 2017-05-23
- Report Code: REP-GB-3984
-
Format:
An Incisive, In-depth Analysis on the Companion Animal Speciality Drugs Market
This study offers a comprehensive, 360 degree analysis on the Companion Animal Speciality Drugs market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Companion Animal Speciality Drugs market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
The largest segment by distribution channel – the veterinary clinics segment – is the most attractive segment in the global market
The Veterinary Clinics segment is the largest segment by distribution channel, which is estimated to create more than US$ 12 Bn, or more than 40% share of the total market in 2017. The Veterinary Clinics segment is expected to create absolute $ opportunity of more than US$ 640 Mn in 2017 over 2016. By the end of 2027, the Veterinary Clinics segment is projected to reach more than US$ 21 Bn or more than 45% share of the total market, expanding at a CAGR of 5.8% over the forecast period. The Veterinary Clinics distribution channel segment dominated the global companion animal speciality drugs market in terms of revenue in 2016, and the trend is projected to continue throughout the forecast period. Veterinary Clinics is also the most attractive segment, with a market attractiveness index of 1.6 over the forecast period.
Rising obesity in pets is one of the major factors boosting the growth of the Veterinary Clinics segment in the global companion animal speciality drugs market
The growing popularity of veterinarians across the globe as a profession has been contributing to an increase in revenue for the Veterinary Clinics distribution channel segment. This is because most people with pets prefer going to a veterinary clinic to obtain prescription drugs rather than opting for self-selection of over-the-counter medications. Globally, hospitals and clinics represent 80% of the service distribution channel for veterinary drugs. Furthermore, increasing tendency to overfeed pets has been resulting in rising obesity in pets globally. This has been negatively impacting the health of pets, thus making them susceptible to more diseases, hence driving demand in the Veterinary Clinics segment.
With growing urbanisation and increasing spread of isolated family units, humanisation of animals is a trend that is growing increasingly across the globe. Adoption of pets as companions has been increasing worldwide, which is specifically driving the need for medicines, preventive treatments and proper hygiene for companion animals. This particular factor is boosting the development of the Veterinary Clinics segment in the global companion animal speciality drugs market.
Increasing urbanisation and growing affluence levels have been driving the adoption of pets, thus driving the demand for pet healthcare services as well. However, it is interesting to note that with rising urbanisation, there has been increasing prevalence of various diseases such as allergies, lower appetite, reduced energy and behavioural anxieties among small companion animals. This has been driving demand for and growth of the Veterinary Clinics segment in the global companion animal speciality drugs market.
Performance analysis of the Veterinary Clinics segment across key regional companion animal speciality drugs markets
The Veterinary Clinics segment dominated the Western Europe companion animal speciality drugs market by distribution channel in terms of revenue in 2016 and the trend is projected to grow throughout the forecast period. Veterinary Clinics is the most attractive segment in the Western Europe regional market, with a market attractiveness index of 1.9 over the forecast period. The Veterinary Clinics segment is anticipated to register a CAGR of 3.3% in terms of value in the North America companion animal speciality drugs market. In APEJ, revenue from the Veterinary Clinics segment is anticipated to increase at a CAGR of 6.5% over the forecast period to reach a market valuation in excess of US$ 2,300 Mn by 2027. Veterinary Clinics is the most attractive segment in the APEJ companion animal speciality drugs market, with an attractiveness index of 1.4 over the forecast period.
In a new publication titled “Companion Animal Speciality Drugs Market: Global Industry Analysis and Opportunity Assessment 2017-2027,” Future Market Insights leverages the Porters Five Forces Model to present insightful research findings on the performance of the global companion animal speciality drugs market over a 10 year forecast period 2017 – 2027. According to the report, the popularity of generic drugs is increasing in the companion animal market, and thus can be a potential threat to branded prescription equivalents, which are highly matured products. After applying the Porters Five Forces Model to examine this market, we have observed that fluctuations in pathogenesis and outbreak patterns of diseases and fluctuating supply of companion/production animal products in the market is expected to lower bargaining power of buyers. Furthermore, our analysts have arrived at a conclusion that there is medium level threat by the entry of generic drug manufacturers and compound pharmacies. There can also be influx of start-up research enterprises through government support for biotechnology/research. Our research also suggests that the market for anti-obesity prescription drugs usage in pets is limited to North America and marginally in Australia. For all other regions these drugs have unauthorised/off-label usage. We have observed the following traits while inspecting the global companion animal speciality drugs market:
-
Increasing distribution channels in emerging economies by established Western players is likely to create differences in revenue generation
-
Product and process innovation assessed in terms of reinvestment of profits to R&D expenses is anticipated to create major differences in market approach by key players
-
Increased demand for parasiticides is expected to contribute the most towards future revenue growth
-
Branded drugs are much preferred over generics and compounded companion animal drugs
-
Parasiticides and vaccines are the key segments by product accounting for the largest revenue generation
-
Branded drugs are much preferred over generics and compounded companion animal drugs
-
Increased demand for parasiticides is expected to contribute the most towards future revenue growth
Report Structure
We have covered the various market segments extensively while examining the global companion animal speciality drugs market and have touched all the aspects of the different sub-segments. Market analysis has been done in terms of Basis Point Share, and Y-o-Y growth projections have also been covered for every segment. This extensive report focusses on highlighting sales of companion animal speciality drugs across the globe. Macro-economic indicators such as adoption of pets, number of pets by country and availability of veterinary clinics have been considered to arrive at the indicated market numbers. For Anti-Obesity drugs, product dossiers have been considered and market numbers have been derived from primary research as most drugs are being used in an unauthorised manner. Top-down approach has been used to counter-validate the reached numbers for the global companion animal speciality drugs market. Parent company financial statements have been analysed to track margins. We have collected this insightful information through sources such as annual reports, publications and companion animal speciality drugs manufacturer presentations. Veterinary journals, product dossiers, government websites, NCBI and case reports have also been referred to while studying this market.
Market Segmentation
|
By Product Type |
By Distribution Channel |
By Region |
|---|---|---|
|
|
|
Research Methodology
We have used in-depth secondary research to ascertain the overall market size, top industry players, products and industry associations. In order to conduct expert and industry interviews, Future Market Insights has formulated a detailed discussion guide. Our analysts have conducted interviews with industry experts, players, distributors and retailers. The forecast presented in the report assesses the total revenue of the global companion animal speciality drugs market. When developing the market forecast, the starting point involves sizing the current market, which forms the basis for the forecast of how the market is anticipated to take shape in the near future. Given the characteristics of the market, we have triangulated the outcome on the basis of analysis based on supply and demand sides. The report also takes into consideration year-on-year growth to understand the predictability of the market and to identify the right opportunities across the global companion animal speciality drugs market. As previously highlighted, the market for global companion animal speciality drugs is split into various segments. All these segments have been analysed in terms of basis point share to understand each individual segment’s relative contribution to overall market growth. This detailed level of information is important for identifying the various key trends in the global companion animal speciality drugs market.
Companion Animal Speciality Drugs Market Reports - Table of Contents
1. Executive Summary
16. Assumptions and Acronyms Used
17. Research Methodology
Companion Animal Speciality Drugs Market Reports - List of Tables
Table 01: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product Type, 2015 – 2027
Table 02: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2027
Table 03: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Region, 2015 – 2027
Table 04: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2015 – 2027
Table 05: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2015 – 2027
Table 06: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2027
Table 07: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2015 – 2027
Table 08: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2015 – 2027
Table 09: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2027
Table 10: Western Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2015 – 2027
Table 11: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2015 – 2027
Table 12: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2027
Table 13: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2015 – 2027
Table 14: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2015 – 2027
Table 15: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2027
Table 16: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2015 – 2027
Table 17: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2015 – 2027
Table 18: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2027
Table 19 : Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast, 2015 – 2027
Table 20: Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2015 – 2027
Table 21: Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2027
Table 22: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2017 – 2027
Table 23: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2015 – 2027
Table 24: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2027
Companion Animal Speciality Drugs Market Reports - List of Figures
Figure 01: Global Companion Animal Drugs Market Size (US$ Mn) By Product Type, 2017 & 2027
Figure 02: Global Companion Animal Drugs Market Share Analysis (%) By Product Type, 2017 & 2027
Figure 03: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Product Type, 2017-2027
Figure 04: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Antibiotics Segment, 2016 – 2027
Figure 05: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Anti-inflammatory Drugs Segment, 2016 – 2027
Figure 06: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Parasiticides Segment, 2016 – 2027
Figure 07: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Heartworm Segment, 2016 – 2027
Figure 08: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Behavioral Products Segment, 2016 – 2027
Figure 09: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) Nutritional Products Segment, 2016 – 2027
Figure 10: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Anti-Obesity Drugs Segment, 2016 – 2027
Figure 11: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Skin Care Products Segment, 2016 – 2027
Figure 12: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Vaccines Segment, 2016 – 2027
Figure 13: Global Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2017-2027
Figure 14 : Global Companion Animal Drugs Market Size (US$ Mn) By Distribution Channel, 2017 & 2027
Figure 15: Global Companion Animal Drugs Market Share by Distribution Channel, 2017-2027
Figure 16: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Distribution Channel, 2017 – 2027
Figure 17: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Veterinary Hospitals Segment, 2016 – 2027
Figure 18: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Veterinary Clinics Segment, 2016 – 2027
Figure 19: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Pharmacies and Drug Stores Segment, 2016 – 2027
Figure 20: Global Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2017-2027
Figure 21: Global Companion Animal Drugs Market Size (US$ Mn) By Region, 2017 & 2027
Figure 22: Global Companion Animal Drugs Market Share Analysis (%) By Region, 2017 & 2027
Figure 23: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Region, 2017 – 2027
Figure 24: North America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 25: Latin America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 26: Western Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 27: Eastern Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 28: APEJ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 29: Japan Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 30: MEA Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 31: Global Companion Animal Drugs Market Attractiveness Analysis By Region, 2017-2027
Figure 32: North America Companion Animal Drugs Market Share Analysis (%) By Country, 2017 - 2027
Figure 33: North America Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2017 – 2027
Figure 34: The U.S. Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),
Figure 35: Canada Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),
Figure 36: North America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2017-2027
Figure 37: North America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2017-2027
Figure 38: Global Companion Animal Drugs Market Attractiveness Analysis By Country, 2017-2027
Figure 39: Latin America Companion Animal Drugs Market Share Analysis (%) By Country, 2017-2027
Figure 40: Latin America Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2017 – 2027
Figure 41: Brazil Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 42: Mexico Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 43: Argentina Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 44: Rest of Latin America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 45: Latin America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2017-2027
Figure 46: Latin America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2017-2027
Figure 47: Latin America Companion Animal Drugs Market Attractiveness Analysis By Country, 2017-2027
Figure 48: Western Europe Companion Animal Drugs Market Share Analysis (%) By Country, 2017 & 2027
Figure 49: Western Europe Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2017 – 2027
Figure 50: U.K. Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 51: Germany Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 52: France Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),
Figure 53: Italy Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 54: Spain Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 55: Nordic Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),
Figure 56: Benelux Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 57: Rest of Western Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 58: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2017-2027
Figure 59: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2017-2027
Figure 60: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Country, 2017-2027
Figure 61: Eastern Europe Companion Animal Drugs Market Share Analysis (%) By Country, 2017-2027
Figure 62: Eastern Europe Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2017 – 2027
Figure 63: Russia Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 64: Poland Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 65: Rest of Eastern Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 66: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2017-2027
Figure 67: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2017-2027
Figure 68: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Country, 2017-2027
Figure 69: APEJ Companion Animal Drugs Market Share Analysis (%) By Country, 2017 & 2027
Figure 70: APEJ Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2017 – 2027
Figure 71: China Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 72: India Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 73: A&NZ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 74: ASEAN Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 75: Rest of APEJ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 76: APEJ Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2017-2027
Figure 77: APEJ Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2017-2027
Figure 78: APEJ Companion Animal Drugs Market Attractiveness Analysis By Country, 2017-2027
Figure 79: Japan Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 80: Japan Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2017-2027
Figure 81: Japan Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2017-2027
Figure 82: MEA Companion Animal Drugs Market Share Analysis (%) By Country, 2017 & 2027
Figure 83: MEA Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2017 – 2027
Figure 84: GCC countries Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 85: South Africa Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 86: Rest of MEA Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2016 – 2027
Figure 87: North America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2017-2027
Figure 88: North America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2017-2027
Figure 89: MEA Companion Animal Drugs Market Attractiveness Analysis By Country, 2017-2027
Get in touch
Harish Tiwari
Global Head - Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.